1. Home
  2. VRAX vs ZNB Comparison

VRAX vs ZNB Comparison

Compare VRAX & ZNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$0.61

Market Cap

972.3K

Sector

Health Care

ML Signal

N/A

Logo Zeta Network Group Class A Ordinary Shares

ZNB

Zeta Network Group Class A Ordinary Shares

N/A

Current Price

$0.71

Market Cap

1.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
VRAX
ZNB
Founded
2013
2002
Country
United Kingdom
China
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Engineering & Construction
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
972.3K
1.0M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
VRAX
ZNB
Price
$0.61
$0.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
537.1K
★ 2.5M
Earning Date
11-20-2026
10-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.10
52 Week High
$13.19
$9.78

Technical Indicators

Market Signals
Indicator
VRAX
ZNB
Relative Strength Index (RSI) 21.31 44.87
Support Level $0.15 $0.22
Resistance Level $1.57 $1.93
Average True Range (ATR) 0.17 0.23
MACD -0.02 0.03
Stochastic Oscillator 10.47 35.90

Price Performance

Historical Comparison
VRAX
ZNB

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

About ZNB Zeta Network Group Class A Ordinary Shares

Zeta Network Group is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.

Share on Social Networks: